Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Harvard Bioscience
(NASDAQ:HBIO)
Intraday
$3.62
0.06
[1.69%]
After-Hours
$3.62
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$3.62
0.06
[1.69%]
At close: Apr 26
$3.62
0
[0.00%]
After Hours: 4:20PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Harvard Bioscience Stock (NASDAQ:HBIO)
Harvard Bioscience Stock (NASDAQ: HBIO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 09, 2024
Harvard Bioscience Expects Overall Run Rate Savings Of ~$4M Beginning In Q2 2024; Expects Q2 Restructuring-Related Charges Of ~$0.5M
Benzinga Newsdesk
-
Apr 9, 2024, 9:15AM
Thursday, March 07, 2024
Harvard Bioscience Q4 Adj EPS $0.04 Misses $0.05 Estimate, Sales $28.15M Miss $29.11M Estimate
Benzinga Newsdesk
-
Mar 7, 2024, 7:02AM
Earnings Scheduled For March 7, 2024
Benzinga Insights
-
Mar 7, 2024, 4:49AM
Wednesday, March 06, 2024
A Preview Of Harvard Bioscience's Earnings
Benzinga Insights
-
Mar 6, 2024, 3:01PM
Harvard Bioscience To Showcase Latest Solutions For Preclinical And Organoid Applications At Society Of Toxicology Meeting
Benzinga Newsdesk
-
Mar 6, 2024, 8:40AM
Tuesday, November 07, 2023
Considering Headwinds In Asia, Harvard Bioscience Expects FY23 Revenue To Be Approximately Flat As Compared To 2022 Versus $116M-$120M Expected Earlier And Consensus Of $116.95M
Benzinga Newsdesk
-
Nov 7, 2023, 7:38AM
Harvard Bioscience Q3 Adjusted EPS $0.01 Misses $0.04 Estimate, Sales $25.36M Miss $28.02M Estimate
Benzinga Newsdesk
-
Nov 7, 2023, 7:08AM
Earnings Scheduled For November 7, 2023
Benzinga Insights
-
Nov 7, 2023, 6:34AM
Monday, November 06, 2023
Earnings Preview For Harvard Bioscience
Benzinga Insights
-
Nov 6, 2023, 2:02PM
Monday, September 18, 2023
Harvard Bioscience And Etisense Announce Agreement For Supply And Distribution Of DECRO Miniature Telemetry Jacket Platform For Pre-Clinical Research
Benzinga Newsdesk
-
Sep 18, 2023, 8:58AM
Wednesday, August 30, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Aug 30, 2023, 9:06AM
Tuesday, August 08, 2023
Harvard Bioscience Expects FY23 Revenues Of $116M-$120M; Consensus $120.76M
Benzinga Newsdesk
-
Aug 8, 2023, 7:38AM
Harvard Bioscience Q2 Adj EPS $0.04 Misses $0.05 Estimate, Sales $28.80M Miss $29.50M Estimate
Benzinga Newsdesk
-
Aug 8, 2023, 7:20AM
Earnings Scheduled For August 8, 2023
Benzinga Insights
-
Aug 8, 2023, 4:48AM
Monday, August 07, 2023
Preview: Harvard Bioscience's Earnings
Benzinga Insights
-
Aug 7, 2023, 5:01PM
Thursday, June 22, 2023
Benchmark Reiterates Speculative Buy on Harvard Bioscience, Maintains $7 Price Target
Benzinga Newsdesk
-
Jun 22, 2023, 8:24AM
Harvard Bioscience Set to Join Russell 2000 and 3000 Indexes
Charles Gross
-
Jun 22, 2023, 7:56AM
Tuesday, June 20, 2023
Harvard Bioscience Appoints Jennifer Cote As Chief Financial Officer
Benzinga Newsdesk
-
Jun 20, 2023, 8:02AM
Wednesday, April 26, 2023
Benchmark Maintains Buy on Harvard Bioscience, Raises Price Target to $7
Benzinga Newsdesk
-
Apr 26, 2023, 6:58AM
Keybanc Maintains Overweight on Harvard Bioscience, Raises Price Target to $7
Benzinga Newsdesk
-
Apr 26, 2023, 5:09AM
Tuesday, April 25, 2023
Harvard Bioscience Q1 Adj. EPS $0.06 Beats $0.05 Estimate, Sales $29.98M Beat $28.85M Estimate
Benzinga Newsdesk
-
Apr 25, 2023, 8:08AM
Tuesday, April 18, 2023
Harvard Bioscience Announces Initial Order For Integrated Animal Behavior Monitoring System; Terms Not Disclosed
Michael Horton
-
Apr 18, 2023, 5:10PM
Monday, April 17, 2023
Top 5 Health Care Stocks That May Fall Off A Cliff This Quarter
Lisa Levin
-
Apr 17, 2023, 8:51AM
Thursday, March 16, 2023
Over $7M Bet On This Consumer Defensive Stock? Check Out These 4 Penny Stocks Insiders Are Buying
Lisa Levin
-
Mar 16, 2023, 9:05AM
Tuesday, March 14, 2023
Harvard Bioscience's Return On Capital Employed Overview
Benzinga Insights
-
Mar 14, 2023, 10:46AM
Friday, March 10, 2023
Benchmark Reiterates Buy on Harvard Bioscience, Maintains $4 Price Target
Benzinga Newsdesk
-
Mar 10, 2023, 10:43AM
Thursday, March 09, 2023
Harvard Bioscience Expects 2023 Reported Revenue Growth In Low-To-Mid Single Digits, Improving Gross Margin, Significant Expansion Of Adjusted EBITDA Margins
Benzinga Newsdesk
-
Mar 9, 2023, 7:07AM
Harvard Bioscience Q4 Adj EPS $0.04 Beats $0.03 Estimate, Sales $28.43M Miss $30.33M Estimate
Benzinga Newsdesk
-
Mar 9, 2023, 7:03AM
Earnings Scheduled For March 9, 2023
Benzinga Insights
-
Mar 9, 2023, 5:00AM
Wednesday, March 08, 2023
Earnings Preview: Harvard Bioscience
Benzinga Insights
-
Mar 8, 2023, 12:01PM
Monday, December 12, 2022
Harvard Bioscience Announces CFO Transition, Michael Rossi To Retire Effective December 31; Appointed Jennifer Cote, The Company's Vice President Of Global Finance, As Its Interim CFO And Treasurer
Benzinga Newsdesk
-
Dec 12, 2022, 8:40AM
Wednesday, November 09, 2022
Keybanc Maintains Overweight on Harvard Bioscience, Lowers Price Target to $5
Benzinga Newsdesk
-
Nov 9, 2022, 4:50AM
Tuesday, November 08, 2022
Harvard Bioscience Q3 EPS $(0.01) Misses $0.07 Estimate, Sales $26.92M Miss $28.89M Estimate
Benzinga Newsdesk
-
Nov 8, 2022, 4:03PM
Earnings Scheduled For November 8, 2022
Benzinga Insights
-
Nov 8, 2022, 4:32AM
Monday, November 07, 2022
Earnings Preview: Harvard Bioscience
Benzinga Insights
-
Nov 7, 2022, 12:23PM
Tuesday, September 27, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 27, 2022, 12:42PM
Monday, September 26, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Sep 26, 2022, 2:09PM
Tuesday, September 20, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 20, 2022, 12:04PM
Friday, September 16, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Sep 16, 2022, 2:08PM
Tuesday, August 30, 2022
$2.4M Bet On This Consumer Cyclical Stock? Check Out These 4 Penny Stocks Insiders Are Buying
Lisa Levin
-
Aug 30, 2022, 10:05AM
Monday, August 22, 2022
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Aug 22, 2022, 5:38PM
Friday, August 19, 2022
Harvard Bioscience Chief Executive Officer Trades $127K In Company Stock
Benzinga Insights
-
Aug 19, 2022, 10:41AM
$92 Million Bet On This Penny Stock? Also Check Out Other 3 Stocks Under $5 Insiders Are Buying
Lisa Levin
-
Aug 19, 2022, 8:15AM
Friday, August 12, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Aug 12, 2022, 12:00PM
Friday, August 05, 2022
Keybanc Maintains Overweight on Harvard Bioscience, Lowers Price Target to $7
Benzinga Newsdesk
-
Aug 5, 2022, 9:19AM
Thursday, May 19, 2022
Looking Into Harvard Bioscience's Return On Capital Employed
Benzinga Insights
-
May 19, 2022, 10:03AM
Thursday, May 05, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
May 5, 2022, 11:38AM
81 Biggest Movers From Yesterday
Lisa Levin
-
May 5, 2022, 4:31AM
Wednesday, May 04, 2022
50 Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
May 4, 2022, 1:45PM
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
May 4, 2022, 12:29PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch